Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

VALHI REPORTS SECOND QUARTER 2026 RESULTS

VALHI REPORTS SECOND QUARTER 2026 RESULTS

Valhi, Inc. reported net income of $22.3 million ($0.78 per share) in Q2 2026, a significant increase from $0.9 million ($0.03 per share) in Q2 2025. The company's Chemicals segment showed strong sales and operating income growth due to market share gains, cost reductions, and strategic price increases. The Component Products segment also experienc…

ESCO Reports Third Quarter Fiscal 2026 Results

ESCO Reports Third Quarter Fiscal 2026 Results

ESCO Technologies Inc. announced a strong third quarter fiscal 2026 performance, highlighting a 14% increase in sales to $339 million, a 38% increase in adjusted EPS to $2.20, and record backlog of $1.54 billion. The company raised its full-year sales guidance to $1.30-$1.33 billion and adjusted EPS guidance to $8.30-$8.40, signaling robust growth …

Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update

Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update

Cognition Therapeutics reported Q2 2026 financial results highlighting progress in their Phase 3 clinical trial planning for zervimesine (CT1812), a treatment for dementia with Lewy bodies (DLB) psychosis. They received FDA feedback clarifying trial design, secured a patent allowance extending intellectual property protection through 2045, and exte…

Alta Equipment Group Announces Second Quarter 2026 Financial Results

Alta Equipment Group Announces Second Quarter 2026 Financial Results

Alta Equipment Group Inc. reported its second quarter 2026 financial results, showing sequential revenue growth across all segments despite a slight year-over-year revenue decline. The company improved new and used equipment sales gross margins, service gross profit percentages, and reduced interest expenses. Adjusted EBITDA remained stable year-ov…

Applied Optoelectronics Reports Second Quarter 2026 Results

Applied Optoelectronics Reports Second Quarter 2026 Results

Applied Optoelectronics, Inc. reported a strong second quarter 2026 with record revenue of $191.9 million, marking the fifth consecutive quarter of growth. The company returned to non-GAAP profitability with net income of $5.5 million and saw a doubling in volume for its 800G products. The outlook remains positive with expected revenue growth and e…

iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care

iRhythm Holdings, Inc. announced the acquisition of VitalConnect, a wearable biosensor and ambulatory cardiac monitoring company, for approximately $287.5 million. The acquisition expands iRhythm's cardiac monitoring portfolio to include mobile cardiac telemetry and multi-vitals monitoring across ambulatory, inpatient, and hospital-to-home care set…

CVRx Reports Second Quarter 2026 Financial and Operating Results

CVRx Reports Second Quarter 2026 Financial and Operating Results

CVRx, Inc. announced a 16% increase in total revenue for Q2 2026 compared to the prior year, driven primarily by U.S. sales growth and expanded active implanting centers. Despite revenue gains and improved reimbursement policies—including new Medicare Advantage coverage from Humana—the company updated its full-year outlook lower due to fewer sales …

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. announced strong financial results for Q2 2026, highlighted by record revenue, annual contract value plus royalties growing 44% year-over-year to $99.5 million, and robust design start activity increasing 21% year-over-year. The company updated its guidance for Q3 and full year 2026, reflecting confidence in its growth driven by AI-en…

Tyson Foods Announces Quarterly Dividend

Tyson Foods Announces Quarterly Dividend

Tyson Foods, Inc. announced a quarterly dividend of $0.51 per Class A share and $0.459 per Class B share, payable December 15, 2026. This dividend reaffirmation reflects Tyson's solid financial position and commitment to returning value to shareholders.

iRhythm Holdings Announces Second Quarter 2026 Financial Results

iRhythm Holdings Announces Second Quarter 2026 Financial Results

iRhythm Holdings announced its Q2 2026 financial results, highlighting a 20.1% revenue increase to $224.2 million, improved gross margins to 72.8%, and near breakeven GAAP net loss with a significant improvement compared to the prior year. The company raised its full-year 2026 revenue and adjusted EBITDA margin guidance, entered a definitive agreem…

Nano Dimension Reports Financial Results for the Second Quarter 2026

Nano Dimension Reports Financial Results for the Second Quarter 2026

Nano Dimension Ltd. reported Q2 2026 revenue of $29 million, a 12.1% year-over-year increase driven by the Essemtec product line. Gross margin improved significantly to 45.9% from 27.3% last year. The company is executing strategic actions including the sale of MarkForged, Inc. to Stratasys and the sale of AME and Fabrica product lines, expected to…

Oculis Reports Q2 2026 Financial Results and Provides Company Update

Oculis Reports Q2 2026 Financial Results and Provides Company Update

Oculis Holding AG announced its Q2 2026 financial results and significant progress in its pivot to neuro-ophthalmology. The company is advancing its lead late-stage asset, Privosegtor, in the PIONEER registrational program for optic neuritis and acute multiple sclerosis relapses following positive FDA pre-IND feedback. Enrollment in the Licaminlima…